These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26772638)

  • 1. Profiling the human hippocampal proteome at all pathologic stages of Alzheimer's disease.
    Hondius DC; van Nierop P; Li KW; Hoozemans JJ; van der Schors RC; van Haastert ES; van der Vies SM; Rozemuller AJ; Smit AB
    Alzheimers Dement; 2016 Jun; 12(6):654-68. PubMed ID: 26772638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LMD proteomics provides evidence for hippocampus field-specific motor protein abundance changes with relevance to Alzheimer's disease.
    Schrötter A; Oberhaus A; Kolbe K; Seger S; Mastalski T; El Magraoui F; Hoffmann-Posorske E; Bohnert M; Deckert J; Braun C; Graw M; Schmitz C; Arzberger T; Loosse C; Heinsen H; Meyer HE; Müller T
    Biochim Biophys Acta Proteins Proteom; 2017 Jun; 1865(6):703-714. PubMed ID: 28377147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Src signaling and post-synaptic actin polymerization in Alzheimer's disease mice hippocampus--linking NMDA receptors and the reelin pathway.
    Mota SI; Ferreira IL; Valero J; Ferreiro E; Carvalho AL; Oliveira CR; Rego AC
    Exp Neurol; 2014 Nov; 261():698-709. PubMed ID: 25128699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of microdissected neurons by 18O mass spectrometry reveals altered protein expression in Alzheimer's disease.
    Hashimoto M; Bogdanovic N; Nakagawa H; Volkmann I; Aoki M; Winblad B; Sakai J; Tjernberg LO
    J Cell Mol Med; 2012 Aug; 16(8):1686-700. PubMed ID: 21883897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics Analysis of CA1 Region of the Hippocampus in Pre-, Progression and Pathological Stages in a Mouse Model of the Alzheimer's Disease.
    Gurel B; Cansev M; Koc C; Ocalan B; Cakir A; Aydin S; Kahveci N; Ulus IH; Sahin B; Basar MK; Baykal AT
    Curr Alzheimer Res; 2019; 16(7):613-621. PubMed ID: 31362689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics analysis of the Alzheimer's disease hippocampal proteome.
    Sultana R; Boyd-Kimball D; Cai J; Pierce WM; Klein JB; Merchant M; Butterfield DA
    J Alzheimers Dis; 2007 May; 11(2):153-64. PubMed ID: 17522440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Stage Alterations in CA1 Extracellular Region Proteins Indicate Dysregulation of IL6 and Iron Homeostasis in the 5XFAD Alzheimer's Disease Mouse Model.
    Gurel B; Cansev M; Sevinc C; Kelestemur S; Ocalan B; Cakir A; Aydin S; Kahveci N; Ozansoy M; Taskapilioglu O; Ulus IH; Başar MK; Sahin B; Tuzuner MB; Baykal AT
    J Alzheimers Dis; 2018; 61(4):1399-1410. PubMed ID: 29376847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease.
    Ginsberg SD; Alldred MJ; Che S
    Neurobiol Dis; 2012 Jan; 45(1):99-107. PubMed ID: 21821124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.
    Zelaya MV; Pérez-Valderrama E; de Morentin XM; Tuñon T; Ferrer I; Luquin MR; Fernandez-Irigoyen J; Santamaría E
    Oncotarget; 2015 Nov; 6(37):39437-56. PubMed ID: 26517091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative proteomic analysis of the hippocampus in the 5XFAD mouse model at early stages of Alzheimer's disease pathology.
    Hong I; Kang T; Yoo Y; Park R; Lee J; Lee S; Kim J; Song B; Kim SY; Moon M; Yun KN; Kim JY; Mook-Jung I; Park YM; Choi S
    J Alzheimers Dis; 2013; 36(2):321-34. PubMed ID: 23603400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SWATH analysis of the synaptic proteome in Alzheimer's disease.
    Chang RY; Etheridge N; Nouwens AS; Dodd PR
    Neurochem Int; 2015 Aug; 87():1-12. PubMed ID: 25958317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postsynaptic Proteome of Non-Demented Individuals with Alzheimer's Disease Neuropathology.
    Zolochevska O; Bjorklund N; Woltjer R; Wiktorowicz JE; Taglialatela G
    J Alzheimers Dis; 2018; 65(2):659-682. PubMed ID: 30103319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology.
    Rosenberger AF; Hilhorst R; Coart E; García Barrado L; Naji F; Rozemuller AJ; van der Flier WM; Scheltens P; Hoozemans JJ; van der Vies SM
    J Alzheimers Dis; 2016; 49(4):927-43. PubMed ID: 26519433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer's disease.
    Zhang Q; Ma C; Gearing M; Wang PG; Chin LS; Li L
    Acta Neuropathol Commun; 2018 Mar; 6(1):19. PubMed ID: 29490708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease.
    Blalock EM; Buechel HM; Popovic J; Geddes JW; Landfield PW
    J Chem Neuroanat; 2011 Oct; 42(2):118-26. PubMed ID: 21756998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease.
    Bossers K; Wirz KT; Meerhoff GF; Essing AH; van Dongen JW; Houba P; Kruse CG; Verhaagen J; Swaab DF
    Brain; 2010 Dec; 133(Pt 12):3699-723. PubMed ID: 20889584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease.
    Kitamura Y; Usami R; Ichihara S; Kida H; Satoh M; Tomimoto H; Murata M; Oikawa S
    Neurol Res; 2017 Mar; 39(3):231-238. PubMed ID: 28107809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micellar extraction possesses a new advantage for the analysis of Alzheimer's disease brain proteome.
    Musunuri S; Kultima K; Richard BC; Ingelsson M; Lannfelt L; Bergquist J; Shevchenko G
    Anal Bioanal Chem; 2015 Feb; 407(4):1041-57. PubMed ID: 25416231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptic Proteome Compensation and Resilience to Psychosis in Alzheimer's Disease.
    Krivinko JM; Erickson SL; Ding Y; Sun Z; Penzes P; MacDonald ML; Yates NA; Ikonomovic MD; Lopez OL; Sweet RA; Kofler J
    Am J Psychiatry; 2018 Oct; 175(10):999-1009. PubMed ID: 30021459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial DNA copy numbers in pyramidal neurons are decreased and mitochondrial biogenesis transcriptome signaling is disrupted in Alzheimer's disease hippocampi.
    Rice AC; Keeney PM; Algarzae NK; Ladd AC; Thomas RR; Bennett JP
    J Alzheimers Dis; 2014; 40(2):319-30. PubMed ID: 24448779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.